Chronic myelocytic leukemia is a clonal proliferation of hematopoietic stem cells caused by myeloproliferative disorders.
慢性粒细胞白血病是一种造血干细胞克隆性增殖所致的骨髓增殖性疾病。
Conclusions Telomerase activity could be a useful marker for evaluating malignant clonal proliferation, and it is hopeful to become a new molecular target for monitoring minimal residual leukemia.
结论端粒酶活化与肿瘤的恶性转化密切相关，可作为恶性血液病恶性克隆增殖的分子标志，有希望成为监测微量残留白血病的一个新指标。
Conclusions Telomerase activity could be a useful marker for evaluating malignant clonal proliferation, and it is hopeful to become a new molecular target for monitoring minimal residual leukemia.
结论端粒酶活化与肿瘤的恶性转化密切相关，可作为恶性血液病恶性克隆增殖的分子标志，有希望成为监测微量残留白血病的一个新指标。
应用推荐